Cite
HARVARD Citation
Gupta, M. et al. (n.d.). 9PSafety profile and therapeutic efficacy of one cycle of [177Lu]prostate-specific membrane antigen (PSMA) in end stage metastatic castration-resistant prostate cancer patients with low performance status. Annals of oncology. p. . [Online].